Yuya Sekine

Akita, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Visualizing Baseline Eligibility Across Locally Advanced or Metastatic Urothelial Cancer Trials and Real-World Cohorts.

Visualizing Baseline Eligibility Across Locally Advanced or Metastatic Urothelial Cancer Trials and Real-World Cohorts.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: May 11, 2026

Real-world Outcomes of Adjuvant Nivolumab in High-risk Bladder and Upper Tract Urothelial Carcinoma after Radical Surgery.

Real-world Outcomes of Adjuvant Nivolumab in High-risk Bladder and Upper Tract Urothelial Carcinoma after Radical Surgery.

Journal: European urology open science

Published: April 19, 2026

Visualizing eligibility gaps between muscle-invasive bladder cancer trials and real-world patients.

Visualizing eligibility gaps between muscle-invasive bladder cancer trials and real-world patients.

Journal: Japanese journal of clinical oncology

Published: March 24, 2026

Younger Age Is Associated With Early Urinary Continence Recovery After Robot-Assisted Radical Prostatectomy.

Younger Age Is Associated With Early Urinary Continence Recovery After Robot-Assisted Radical Prostatectomy.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: March 14, 2026

Association of EVITA with safety in advanced urothelial carcinoma: A multicenter real-world study.

Association of EVITA with safety in advanced urothelial carcinoma: A multicenter real-world study.

Journal: Urologic oncology

Published: February 16, 2026

Presenting postoperative mortality as percentages and natural frequencies (1-in-N) in major urologic cancer surgeries.

Presenting postoperative mortality as percentages and natural frequencies (1-in-N) in major urologic cancer surgeries.

Journal: Urologic oncology

Published: December 27, 2025

Association of Prophylactic Intravenous Corticosteroid Premedication With Toxicity and Survival in Patients Receiving Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma.

Association of Prophylactic Intravenous Corticosteroid Premedication With Toxicity and Survival in Patients Receiving Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: November 17, 2025

Deferred Cytoreductive Nephrectomy in Unresectable/Metastatic Renal Cell Carcinoma: A Real-World Multicenter Retrospective Study.

Deferred Cytoreductive Nephrectomy in Unresectable/Metastatic Renal Cell Carcinoma: A Real-World Multicenter Retrospective Study.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: October 14, 2025

The Impact of Early Modification of Upfront Androgen Receptor Signaling Inhibitors on Survival Outcomes in Metastatic Hormone-Sensitive Prostate Cancer.

The Impact of Early Modification of Upfront Androgen Receptor Signaling Inhibitors on Survival Outcomes in Metastatic Hormone-Sensitive Prostate Cancer.

Journal: The Prostate

Published: September 18, 2025

Biopsy Gleason score 5 + 4 predicts worse outcomes than 4 + 5 after robot-assisted radical prostatectomy: a nationwide multicenter cohort study.

Biopsy Gleason score 5 + 4 predicts worse outcomes than 4 + 5 after robot-assisted radical prostatectomy: a nationwide multicenter cohort study.

Journal: World journal of urology

Published: September 05, 2025

Inhibition of Fatty Acid-Binding Protein 4 Limits High-Fat-Diet-Associated Prostate Tumorigenesis and Progression in TRAMP Mice.

Inhibition of Fatty Acid-Binding Protein 4 Limits High-Fat-Diet-Associated Prostate Tumorigenesis and Progression in TRAMP Mice.

Journal: International journal of molecular sciences

Published: August 27, 2025

Comparison of IO-IO and IO-TKI Treatment Outcomes in Metastatic Renal Cell Carcinoma: Influence of Metastatic Site Count.

Comparison of IO-IO and IO-TKI Treatment Outcomes in Metastatic Renal Cell Carcinoma: Influence of Metastatic Site Count.

Journal: Cancer diagnosis & prognosis

Published: August 12, 2025

Showing 1-12 of 43

Last Updated: 09/26/2026